Short Interest in Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Expands By 1,312.5%

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) was the target of a large increase in short interest in December. As of December 31st, there was short interest totalling 33,900 shares, an increase of 1,312.5% from the December 15th total of 2,400 shares. Based on an average daily volume of 1,090,000 shares, the days-to-cover ratio is presently 0.0 days. Currently, 1.2% of the company’s stock are short sold.

Shuttle Pharmaceuticals Stock Up 3.4 %

SHPH traded up $0.03 during trading on Monday, reaching $0.90. 90,245 shares of the company’s stock were exchanged, compared to its average volume of 76,164. The stock has a market capitalization of $3.30 million, a PE ratio of -0.22 and a beta of -1.74. Shuttle Pharmaceuticals has a one year low of $0.58 and a one year high of $4.95. The stock has a fifty day moving average price of $0.88.

About Shuttle Pharmaceuticals

Shuttle Pharmaceuticals Holdings, Inc, a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers .